Executive Leadership & BOD

Chief Medical Officer

about

The Partner
We Worked With

Our partner is focused on developing innovative cancer immunotherapies, particularly targeting immune checkpoint pathways to enhance the body's immune response against tumors. Their approach aims to address unmet needs in oncology and improve patient outcomes through advanced, targeted treatments.

the role

Critical Objectives

This executive leader played a critical role in shaping our partner's strategy, while interfacing with investors and partners. They cultivated the existing pipeline and maneuvered preclinical assets through the clinical process. They also managed an IND for the lead candidate (treatment of Acute Myeloid Leukemia -AML) in Q2 2020.

key metrics

Proven, measurable
results

STAT. 1
3

days until hired candidate presented

STAT. 2
8

candidates presented

STAT. 3
27

days until search completed

Record of Success

Related case studies